BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6432309)

  • 1. Effects of pH and temperature on the stability and decomposition of N,N'N"-triethylenethiophosphoramide in urine and buffer.
    Cohen BE; Egorin MJ; Nayar MS; Gutierrez PL
    Cancer Res; 1984 Oct; 44(10):4312-6. PubMed ID: 6432309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A search for new metabolites of N,N',N''-triethylenethiophosphoramide.
    van Maanen MJ; Tijhof IM; Damen JM; Versluis C; van den Bosch JJ; Heck AJ; Rodenhuis S; Beijnen JH
    Cancer Res; 1999 Sep; 59(18):4720-4. PubMed ID: 10493531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human plasma pharmacokinetics and urinary excretion of thiotepa and its metabolites.
    Cohen BE; Egorin MJ; Kohlhepp EA; Aisner J; Gutierrez PL
    Cancer Treat Rep; 1986 Jul; 70(7):859-64. PubMed ID: 2424593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation study of thiotepa in aqueous solutions.
    van Maanen MJ; Brandt AC; Damen JM; Beijnen JH
    Int J Pharm; 1999 Mar; 179(1):55-64. PubMed ID: 10053202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of thioTEPA and its metabolites, TEPA, monochloroTEPA and thioTEPA-mercapturate, in plasma and urine.
    van Maanen MJ; Doesburg Smits K; Damen JM; Heck AJ; Beijnen JH
    Int J Pharm; 2000 May; 200(2):187-94. PubMed ID: 10867248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Nitrosoamino-3-methylimidazo[4,5-f]quinoline stability and reactivity.
    Lakshmi VM; Hsu FF; Zenser TV
    Chem Res Toxicol; 2004 May; 17(5):709-16. PubMed ID: 15144229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of nonexchangeable radioactivity in L1210 cells incubated with [14C]thiotepa: labeling of phosphatidylethanolamine.
    Egorin MJ; Snyder SW
    Cancer Res; 1990 Jul; 50(13):4044-9. PubMed ID: 2112983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous quantification of cyclophosphamide, 4-hydroxycyclophosphamide, N,N',N"-triethylenethiophosphoramide (thiotepa) and N,N',N"-triethylenephosphoramide (tepa) in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
    de Jonge ME; van Dam SM; Hillebrand MJ; Rosing H; Huitema AD; Rodenhuis S; Beijnen JH
    J Mass Spectrom; 2004 Mar; 39(3):262-71. PubMed ID: 15039933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of human glutathione S-transferase isoenzymes in the formation of glutathione conjugates of the alkylating cytostatic drug thiotepa.
    Dirven HA; Dictus EL; Broeders NL; van Ommen B; van Bladeren PJ
    Cancer Res; 1995 Apr; 55(8):1701-6. PubMed ID: 7712478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of DEET by ozonation in aqueous solution.
    Tay KS; Rahman NA; Abas MR
    Chemosphere; 2009 Aug; 76(9):1296-302. PubMed ID: 19570564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of N,N',N"-triethylenethiophosphoramide and its active metabolite N,N',N"-triethylenephosphoramide in plasma and urine using capillary gas chromatography.
    van Maanen RJ; van Ooijen RD; Zwikker JW; Huitema AD; Rodenhuis S; Beijnen JH
    J Chromatogr B Biomed Sci Appl; 1998 Nov; 719(1-2):103-12. PubMed ID: 9869370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of N,N',N"-triethylenthiophosphoramide in biological samples using capillary gas chromatography.
    van Maanen RJ; van Ooijen RD; Beijnen JH
    J Chromatogr B Biomed Sci Appl; 1997 Sep; 698(1-2):111-21. PubMed ID: 9367199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability experiments in human urine with EO9 (apaziquone): a novel anticancer agent for the intravesical treatment of bladder cancer.
    Vainchtein LD; Rosing H; Mirejovsky D; Lenaz L; Schellens JH; Beijnen JH
    J Pharm Biomed Anal; 2007 Jan; 43(1):285-92. PubMed ID: 16920321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of thioTEPA and its metabolites in patients treated with high-dose cyclophosphamide, thioTEPA and carboplatin.
    van Maanen MJ; Huitema AD; Rodenhuis S; Beijnen JH
    Anticancer Drugs; 2001 Jul; 12(6):519-24. PubMed ID: 11459998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of new potential ACE inhibitor in the aqueous solutions of different pH.
    Roskar R; Simoncic Z; Gartner A; Kmetec V
    J Pharm Biomed Anal; 2009 Feb; 49(2):295-303. PubMed ID: 19135817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability and degradation profiles of Spantide II in aqueous solutions.
    Kikwai L; Babu RJ; Kanikkannan N; Singh M
    Eur J Pharm Sci; 2006 Feb; 27(2-3):158-66. PubMed ID: 16266798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of ramipril in the solvents of different pH.
    Hanysová L; Václavková M; Dohnal J; Klimes J
    J Pharm Biomed Anal; 2005 Apr; 37(5):1179-83. PubMed ID: 15862704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of ricobendazole in aqueous solutions.
    Wu Z; Tucker IG; Razzak M; Medlicott NJ
    J Pharm Biomed Anal; 2009 Jul; 49(5):1282-6. PubMed ID: 19342190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of thioTEPA, TEPA and a novel, recently identified thioTEPA metabolite, monochloroTEPA, in urine using capillary gas chromatography.
    van Maanen MJ; Smits KD; Beijnen JH
    J Chromatogr B Biomed Sci Appl; 2000 Jun; 742(2):335-43. PubMed ID: 10901138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive chemical degradation of bleomycin during attempted labelling with 51-Cr.
    Areberg J; Björkman S
    Nuklearmedizin; 1999; 38(4):120-3. PubMed ID: 10392377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.